NCT06546397View on ClinicalTrials.gov

Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion

PHASE1RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 9, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Pregnancy Complications
Interventions
DRUG

17β-estradiol/dydrogesterone tablets

The medication group began taking 17β-estradiol/dydrogesterone tablets orally for 28 days starting from the first day after induced abortion surgery (taking 2mg of 17β-estradiol orally once a day for the first 14 days, and then taking 2mg of 17β-estradiol + 10mg of dydrogesterone tablets orally once a day for the next 14 days). The blank control group did not take any medication.

Trial Locations (1)

310006

RECRUITING

Women's Hospital School Of Medicine Zhejiang University, Hangzhou

All Listed Sponsors
lead

Women's Hospital School Of Medicine Zhejiang University

OTHER